Tag

Hspcs

All articles tagged with #hspcs

Telomeric DDR blockade rejuvenates aging hematopoiesis
science14 days ago

Telomeric DDR blockade rejuvenates aging hematopoiesis

Therapeutic inhibition of telomeric DNA damage response using telomeric antisense oligonucleotides (tASO) suppresses tDDR signaling in telomerase-deficient mice and physiologically aged mice, reducing cellular senescence and inflammation, restoring hematopoietic tissue architecture, enhancing hematopoietic stem/progenitor cell quiescence and fitness, and improving in vivo repopulation and humoral immune responses; ex vivo human aged CD34+ HSPCs also show improved clonogenic potential. Telomere length is unchanged, indicating relief of dysfunction via tDDR blockade rather than telomere elongation, suggesting tDDR inhibition as a therapeutic strategy for telomere biology disorders and age-related hematopoietic aging.

Skull bone marrow drives immunotolerance in pediatric brain tumors
science5 months ago

Skull bone marrow drives immunotolerance in pediatric brain tumors

New research reveals a skull bone marrow–tumor immune axis in childhood brain cancers: CSF-borne signals educate skull hematopoietic stem and progenitor cells to present tumor antigens via MHC-II, polarizing CD4+ T cells toward regulatory T cells and promoting immunotolerance. Disrupting this axis—by normalizing CSF cytokines, mobilizing skull hematopoiesis, or blocking GM-CSF signaling with mavrilimumab (and even more so when combined with immune checkpoint blockade)—induces tumor regression in mouse models of ZFTA–RELA ependymoma, choroid plexus carcinoma, and group 3 medulloblastoma. The findings identify a skull-tumor immunological interface and suggest targeting local skull hematopoiesis as a potentially less-toxic therapy for aggressive pediatric brain tumors.